(Reuters) Valeant Pharmaceuticals International Inc investor John Paulson trimmed his stake in the Canadian drugmaker but said he remains fully supportive of the company’s leadership. New York-based hedge fund Paulson & Co cut its stake to 6 percent from 6.3 percent, reported in June, due to rebalancing of its portfolios based on asset flows.
Hedge fund Paulson & Co Trims Stake in Valeant
This entry was posted in Syndicated. Bookmark the permalink.
